View All

Alcohol in London: A Cost-Benefit Analysis	Report 2003-01-31	By Michael Spackman et al.
Are Mergers the Right Medicine for Japan's Pharmaceutical Industry?	Presentation 2002-10-20	By Dr. Richard Rapp
Antitrust Issues Between Payers and Providers	Published Article 2002-03-01	By Dr. Thomas McCarthy and Dr. Scott Thomas
Broad-Based Compulsory Licensing of Pharmaceutical Technologies: Unsound Public Policy	Published Article 2001-07-01	By Dr. Richard Rozek et al.
Reimbursing Generics in the UK: Is There a Better Way?	Published Article 2001-03-01	By NERA Special Advisor Ian Senior
The Effects of Compulsory Licensing on Innovation and Access to Health Care	Published Article 2000-11-01	By Dr. Richard Rozek
A Comparables Approach To Measuring Cash-Flow-At-Risk (c-far) For Non-Financial Firms	Working Paper 2000-08-01	By Louis Guth and Dr. Michael Tennican, et al.
Efficiencies Analysis in Hospital Mergers	Published Article 1999-12-01	By Dr. Thomas McCarthy, Dr. Scott Thomas and Dr. Lawrence Wu
A New and Uncertain Future for Managed Care Mergers: An Antitrust Analysis of the Aetna/Prudential Merger	Published Article 1999-10-01	By Dr. Lawrence Wu with Robert Bloch and Scott Perlman
The Costs to the US Health Care System of Extending Marketing Exclusivity for Taxol	Published Article 1999-09-01	By Dr. Richard Rozek
< Back 1 2 3 4 Next >

NERA Economic Consulting